Beer, wine and hors d'oeuvres will be served.
From private placements to public offerings to strategic alliances, life sciences companies have myriad possibilities for funding future growth. But which course is the best course, and what should companies consider when pursuing a particular deal? This discussion, moderated by Pepper attorneys Merrill M. Kraines and David M. Santangelo, along with EisnerAmper partner John Pennett, will examine the latest trends in life sciences financing and present the perspectives of both investors and life sciences companies. Our panelists, Eric Cheng, Senior Managing Director, Head of Healthcare Investment Banking and Ritesh Veera, Managing Director, Investment Banking at Maxim, and Alan Roemer, Senior Vice President, Corporate Development at Roivant Sciences will discuss:
Pepper Hamilton LLP
The New York Times Building
620 Eighth Avenue - 37th Floor
New York, NY 10018-1405
There is no cost to attend.
Contact Kim MacAlister at email@example.com or 215.981.4249 with any questions.